glp 1 vs sglt2 weight loss GLP-1 Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Clinical application of glucagon-like peptide-1

On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said

Adiponectin: Role in Physiology and Pathophysiology

For constipation, the most effective lifestyle changes include slowly increasing dietary fiber, drinking more fluids, and adding at least half an hour of daily physical activity

The present review is aimed at discuss data from studies regarding the anti-cancer effects of several anti-diabetic drugs recently showed in TC in view of their potential repositioning